Question · asked by 1 review
Ketamine vs midazolam: Withdrawals due to adverse events
- Population
- adults (aged 18 years+) with depression in bipolar disorder
- Intervention
- Ketamine
- Comparison
- midazolam
- Outcome
- Withdrawals due to adverse events
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Ketamine vs midazolam Acceptability: dropouts due to adverse effects at 24 hours · adults (aged 18 years+) with depression in bipolar disorder Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder (2021) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 16 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Ketamine vs midazolam · adults with Major Depressive Disorder · 1 review
- Ketamine vs placebo · adults with Major Depressive Disorder · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.